DOI · e01.org

The survival impact of palliative radiotherapy on synchronous metastatic pancreatic ductal adenocarcinoma: metastatic site can serve for radiotherapy-decision

Biaoxiang Xu, Yuan Zhou, Qian Pei, Fengbo Tan, Lilan Zhao, Cenap Güngör, Dan Wang, Yuqiang Li, Wenxue Liu, Zhongyi Zhou · Journal of Cancer · 2021

  • DOI 10.7150/jca.64800
  • Publisher Ivyspring International Publisher
  • Type article
  • Issued 2021

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

Journal of Cancer · Ivyspring International Publisher · article · 2021

Abstract

Background: The metastatic site seems to represent a malignancy with a different biological characteristic and is an important prognostic factor in metastatic pancreatic ductal adenocarcinoma (mPDAC).Palliative radiotherapy is a therapeutic option, and usually used for pain management in the treatment of mPDAC.The real-world effect of radiotherapy on the survival outcomes of mPDAC patients might do exist and is worth exploring.Methods: Data from the Surveillance, Epidemiology, and End Results (SEER) was extracted to identify mPDAC diagnosed in the periods of 2010-2016.The statistical methods included Pearson's chi-square test, Log-rank test, Cox regression model and propensity score matching (PSM).Results: Radiotherapy was able to improve the overall survival of PDAC with liver metastasis (p<0.001),but not for PDAC patients with lung (p=0.130),bone (p=0.451) and brain metastasis (p=0.226)before PSM.Radiotherapy can only a prognostic factor for PDAC liver metastasis (p=0.001) in the cox regression analysis.The survival curves provided consistent results with cox regression analysis (PDAC with liver metastasis: p=0.023,PDAC with lung metastasis: p=0.528,PDAC with bone metastasis: p=0.210,PDAC with brain metastasis: p=0.106) after PSM.We continue to divided PDAC liver patients into PDAC-liver-metastasis with and without lung, bone, and/or brain (LBB) metastasis.Finally, radiotherapy can be used as a feasible treatment to prolong the overall survival of patients with PDAC liver metastasis without LBB metastasis.Conclusions: Radiotherapy can be used as a feasible treatment to prolong the overall survival of patients with PDAC liver metastasis without LBB metastasis.

Open the resolved locator · 10.7150/jca.64800

Metadata licence: OpenAlex metadata (CC0)

Registry
OpenAlex DOI index + API
Fetched
2026-11-19 20:03 UTC
Cache state
not cached yet (bulk-index+openalex)
Locator
https://www.jcancer.org/v13p0385.htm
Metadata licence
OpenAlex metadata (CC0)
Scope
Metadata as returned by the resolver; abstracts are never generated here.